$750 | Single User
$1500 | Site License
$2250 | Global License

Co-Diagnostics Inc - Product Pipeline Analysis, 2018 Update [Report Updated: 27-12-2018]

Published by Global Data: 27 Dec 2018 | 228651 | In Stock

Introduction

Summary

Co-Diagnostics Inc (Co-Diagnostics) is a molecular diagnostics company that develops, manufactures and markets a state-of-the-art diagnostics technology. The company’s products include HCV RNA real-time PCR kit, HIV RNA real-time PCR kit, malaria DNA real-time PCR kit, and TB complex DNA kit. Its products finds application in window period detection in blood screening, viral load for monitoring the success of treatment, and infant diagnosis for detecting disease in infants, among others. The company’s technologies comprise Co-Dx, a suite of mathematically-engineered DNA-based polymerase chain reaction diagnostics products, and Adaptivex which helps primers address the challenge of unexpected mutations. Its technology is designed for new generation mobile point-of-care diagnostic devices, and commercially available devices. Co-Diagnostics is headquartered in Sandy, Utah, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Co-Diagnostics Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Table of Contents
for Co-Diagnostics Inc - Product Pipeline Analysis, 2018 Update [Report Updated: 27-12-2018]

  • Table of Contents

    Table of Contents 2

    List of Tables 4

    List of Figures 4

    Co-Diagnostics Inc Company Overview 5

    Co-Diagnostics Inc Company Snapshot 5

    Co-Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview 5

    Co-Diagnostics Inc – Pipeline Analysis Overview 8

    Co-Diagnostics Inc - Key Facts 8

    Co-Diagnostics Inc - Major Products and Services 9

    Co-Diagnostics Inc Pipeline Products by Development Stage 10

    Co-Diagnostics Inc Pipeline Products Overview 13

    Co-Dx Test - Human Papillomavirus 13

    Co-Dx Test - Human Papillomavirus Product Overview 13

    Co-Dx Test - Gonorrhoea/Chlamydia 14

    Co-Dx Test - Gonorrhoea/Chlamydia Product Overview 14

    Companion Diagnostic Test - Cancer 15

    Companion Diagnostic Test - Cancer Product Overview 15

    Diagnostic Test - Drug Resistant Tuberculosis 16

    Diagnostic Test - Drug Resistant Tuberculosis Product Overview 16

    Diagnostic Test - Heart Disease 17

    Diagnostic Test - Heart Disease Product Overview 17

    Diagnostic Test - Auto-immune Disorder 18

    Diagnostic Test - Auto-immune Disorder Product Overview 18

    Diagnostic Test - Blood Bank Multiplex Test 19

    Diagnostic Test - Blood Bank Multiplex Test Product Overview 19

    Diagnostic Test - Genetic Disorder 20

    Diagnostic Test - Genetic Disorder Product Overview 20

    Diagnostic Test - Health Care-associated Infection 21

    Diagnostic Test - Health Care-associated Infection Product Overview 21

    Diagnostic Test - Hepatitis C 22

    Diagnostic Test - Hepatitis C Product Overview 22

    Diagnostic Test - Infectious Disease 23

    Diagnostic Test - Infectious Disease Product Overview 23

    Diagnostic Test - Oncology 24

    Diagnostic Test - Oncology Product Overview 24

    Diagnostic Test - STD Panel 25

    Diagnostic Test - STD Panel Product Overview 25

    Diagnostic Test - Women's Health 26

    Diagnostic Test - Women's Health Product Overview 26

    LightPCR 27

    LightPCR Product Overview 27

    Co-Diagnostics Inc - Key Competitors 28

    Co-Diagnostics Inc - Key Employees 29

    Co-Diagnostics Inc - Locations And Subsidiaries 30

    Head Office 30

    Other Locations & Subsidiaries 30

    Joint Venture 30

    Recent Developments 31

    Co-Diagnostics Inc, Recent Developments 31

    Jul 17, 2018: Co-Diagnostics Completes Submission of CE Mark Registration for Tuberculosis Screening Test 31

    Jun 11, 2018: Co-Diagnostics to Host Booth at CARPHA Conference 31

    Jun 05, 2018: Co-Diagnostics Announces Advancement of Co-Primers Technology in Multiplex SNP Genotyping 32

    Jun 01, 2018: Co-Diagnostics Announces Participation in Research Project with Stanford University 32

    Mar 22, 2018: Co-Diagnostics Announces Construction Update at JV Manufacturing Facility in India 32

    Feb 28, 2018: Co-Diagnostics Announces Positive Results from Co-Primers Technology in Multiplex Tests for SNP Detection 33

    Feb 21, 2018: Co-Diagnostics Ships Product to India for Validation Study 33

    Dec 19, 2017: Co-Diagnostics Enters Into Lease for New, Upgraded Laboratory Facility 33

    Nov 15, 2017: Co-Diagnostics Reports Q3 Financial Results and Updates Corporate Developments 34

    Nov 07, 2017: Co-Diagnostics Manufacturing Joint Venture Breaks Ground in India 35

    Appendix 36

    Methodology 36

    About GlobalData 39

    Contact Us 39

    Disclaimer 39

List Of Tables
in Co-Diagnostics Inc - Product Pipeline Analysis, 2018 Update [Report Updated: 27-12-2018]

List of Tables

Co-Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview 5

Co-Diagnostics Inc Pipeline Products by Equipment Type 6

Co-Diagnostics Inc Pipeline Products by Indication 7

Co-Diagnostics Inc, Key Facts 8

Co-Diagnostics Inc, Major Products and Services 9

Co-Diagnostics Inc Number of Pipeline Products by Development Stage 10

Co-Diagnostics Inc Pipeline Products Summary by Development Stage 11

Co-Dx Test - Human Papillomavirus - Product Status 13

Co-Dx Test - Human Papillomavirus - Product Description 13

Co-Dx Test - Gonorrhoea/Chlamydia - Product Status 14

Co-Dx Test - Gonorrhoea/Chlamydia - Product Description 14

Companion Diagnostic Test - Cancer - Product Status 15

Companion Diagnostic Test - Cancer - Product Description 15

Diagnostic Test - Drug Resistant Tuberculosis - Product Status 16

Diagnostic Test - Drug Resistant Tuberculosis - Product Description 16

Diagnostic Test - Heart Disease - Product Status 17

Diagnostic Test - Heart Disease - Product Description 17

Diagnostic Test - Auto-immune Disorder - Product Status 18

Diagnostic Test - Auto-immune Disorder - Product Description 18

Diagnostic Test - Blood Bank Multiplex Test - Product Status 19

Diagnostic Test - Blood Bank Multiplex Test - Product Description 19

Diagnostic Test - Genetic Disorder - Product Status 20

Diagnostic Test - Genetic Disorder - Product Description 20

Diagnostic Test - Health Care-associated Infection - Product Status 21

Diagnostic Test - Health Care-associated Infection - Product Description 21

Diagnostic Test - Hepatitis C - Product Status 22

Diagnostic Test - Hepatitis C - Product Description 22

Diagnostic Test - Infectious Disease - Product Status 23

Diagnostic Test - Infectious Disease - Product Description 23

Diagnostic Test - Oncology - Product Status 24

Diagnostic Test - Oncology - Product Description 24

Diagnostic Test - STD Panel - Product Status 25

Diagnostic Test - STD Panel - Product Description 25

Diagnostic Test - Women's Health - Product Status 26

Diagnostic Test - Women's Health - Product Description 26

LightPCR - Product Status 27

LightPCR - Product Description 27

Co-Diagnostics Inc, Key Employees 29

Co-Diagnostics Inc, Subsidiaries 30

Co-Diagnostics Inc, Joint Venture 30

Glossary 38

List Of Figures, Charts and Diagrams
in Co-Diagnostics Inc - Product Pipeline Analysis, 2018 Update [Report Updated: 27-12-2018]

List of Figures

Co-Diagnostics Inc Pipeline Products by Equipment Type 6

Co-Diagnostics Inc Pipeline Products by Development Stage 10

Additional Details

Publisher

Global Data

Publisher Information

Reference

228651 | GDME229854PD

Number of Pages

39

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Non-Small Cell Lung Cancer: Update Bulletin [Jan 2016]
IntroductionGain new KOL insights on the latest events that have the potential to shape the targeted...
01 Jan 2016 by FirstWord Pharma USD $995 More Info
Malignant Melanoma: Update Bulletin [Jan 2016]
IntroductionGain new KOL insights on the latest events happening in Malignant melanoma (MM): Opdivo’...
01 Jan 2016 by FirstWord Pharma USD $995 More Info
Type 2 Diabetes Mellitus: Update Bulletin [Jan 2016]
IntroductionGain new KOL insights on the latest events happening in type 2 diabetes mellitus (T2DM):...
01 Jan 2016 by FirstWord Pharma USD $995 More Info
Value-driven Pharma: Integrating health outcomes across the product lifecycle
IntroductionTwo recessions in a decade, financial austerity, and unprecedented pressure to prove pro...
24 Feb 2014 by FirstWord Pharma USD $695 More Info
Physician Views: How do oncologists use companion diagnostics, what are the key challenges and which pharma companies are best at supporting them?
ScopeAs exemplified by Roche's R&D presentation last week (see Spotlight On: Roche's R&D day – The k...
01 Oct 2013 by FirstWord Pharma USD $695 More Info
Charting the Biosimilar and Biobetter Development Pipeline (2013)
IntroductionIf you need to understand the important biosimilar and biobetter drug developments world...
01 Jul 2013 by FirstWord Pharma USD $2,195 More Info
Effective sales and marketing strategies for drugs with companion diagnostics
IntroductionTo fully exploit the commercial advantages of companion diagnostics, Pharma companies ne...
01 May 2013 by FirstWord Pharma USD $695 More Info
The Path to Product Inclusion in Clinical Guidelines: Strategies for Success
IntroductionClinical guidelines are taking hold in the practice of medicine. Though not always volun...
01 Feb 2013 by FirstWord Pharma USD $695 More Info
Charting the Biosimilar and Biobetter Development Pipeline
IntroductionBiosimilar development has failed to meet expectations in recent years, but that is set ...
01 Sep 2012 by FirstWord Pharma USD $2,195 More Info
New Product Penetration: Understanding & Accelerating New Product Uptake
Introduction"Action is power" This advice is increasingly relevant for pharmaceutical companies when...
01 May 2012 by FirstWord Pharma USD $695 More Info

This report is published by Global Data

Download Free Report Summary PDF

Co-Diagnostics Inc - Product Pipeline Analysis, 2018 Update [Report Updated: 27-12-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data